WP
VRTX icon

WealthPLAN Partners’s Vertex Pharmaceuticals VRTX Stock Holding History

WealthPLAN Partners’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,466
Closed -$687K – 309
2024
Q2 		$687K Buy
+1,466
New +$636K 0.07% 171
2023
Q3 		– Sell
-188
Closed -$66.2K – 1159
2023
Q2 		$66.2K Sell
188
-3
-2% -$1.01K 0.01% 462
2023
Q1 		$60.2K Buy
+191
New +$57.3K 0.01% 518
2016
Q3 		$2.33K Sell
27
-27
-50% -$2.55K ﹤0.01% 834
2016
Q2 		$2.33K Buy
+54
New +$4.67K ﹤0.01% 2218

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return